• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A vehicle speed control device for use in a trolley-assisted dump truck of a single phase alternating current system can control the driving torque in proportion to the amount of depression of an accelerator pedal in the same manner as in the case of running under an engine mode condition even when running under a trolley mode condition utilizing a commercial power source. The device comprises in combination an accelerator valve for controlling compressed air from a reservoir in proportion to the amount of depression of an accelerator pedal, an engine throttle control unit controlled by the compressed air passed through the accelerator valve, an acceleration pattern generator actuated by the compressed air to convert the air pressure into a voltage, a mode converted for sending out a voltage pattern to a main drive circuit of the truck in response to a voltage signal from the acceleration pattern generator, and an engine control solenoid operated valve for selectively controlling supply of the compressed air to the engine throttle control unit and to the acceleration pattern generator.
    公开号:SU1496629A3
    申请号:SU833598649
    申请日:1983-05-26
    公开日:1989-07-23
    发明作者:Teruo Minami
    申请人:Kabusiki Kajsya Komatsu Sejkas；
    IPC主号:
    专利说明:

    The invention relates to medicine, in particular to dermatovenerology.
    The purpose of the invention is to reduce the duration of treatment.
    The method is as follows.
    Along with the standard methods of treatment (antibiotic therapy, bismuth preparations, non-specific therapy), patients are prescribed a course of treatment with elevated partial pressures of oxygen (oxygen therapy). Oxygen barotherapy regimen: oxygen partial pressure of 0.25 MPa (2.5 kgf / cm 2 ), exposure time 60 min, daily, treatment course 10-12 sessions.
    Example 1. Patient B., 59 years old, was hospitalized from 23.11 to 12.12. 1984 with a diagnosis of secondary fresh syphilis; concomitant diseases - hypertension of 2A degree, athero-and cardiosclerosis. Treatment: penicillin 51.2 million units, bitsillin 4.8 million units. Multivitamins, B group vitamins (Wb and B12), and antihypertensive drugs were prescribed as nonspecific stimulating therapy with regard to concomitant diseases. After 2 months after the end of treatment, a course of oxygen therapy was prescribed for positive serological reactions (10 sessions, oxygen partial pressure 0.25 MPa, exposure 60 min, daily). Currently, it is at the dispensary: there are no clinical manifestations of the disease, serological reactions are firmly negative (they were negative three weeks after the end of the course of oxygen therapy).
    Example 2. Patient D., 25 years old, from May 1981 to June 1982, was treated for early latent syphilis. Serological reactions were negative from October 1981 and were persistently negative until September 1984. In September 1984, the reaction of binding complement to the cardiolipin antigen and
    3
    four
    1496794
    sedimentary reactions are negative, and the reaction of binding complement with a treponemal antigen is 4 + 1:10, the reaction of immobilizing pale treponemas is 65%. Repeated reactions from 3.01. 1985: reaction
    binding of complement with treponemal antigen again 4 + 1: 10; sedimentary reactions and the reaction of binding complement to the cardiolipin antigen ^ negative, immunofluorescence reaction - 4 +, the reaction of immobilization of pale treponema - 77%. State of liquor: protein 0.165 g / l, cytosis 5/3, Pandy and None-Appelta 2+ reactions, Lange reaction - 011100000, negative serological reactions, immunofluorescence reaction - 2+, Given the increase in the reaction of immobilization of pale treponem, a sharply positive reaction Wasserman in serum with treponemal antigen and a positive immunofluorescence test in the cerebrospinal fluid for serorecidal, treated according to the scheme of the Central Dermatovenerologic Institute. Nonspecific therapy: group B vitamins, oxygen therapy barotherapy (10 sessions, oxygen partial pressure 0.25 MPa, exposure 60 min, daily). Immunological studies:
    ten
    15
    20
    25
    the total complement titer before oxygen barotherapy was 20 units, after - 30 units, the content of circulating immune complexes - 88 and 87.5 units. respectively, T-active lymphocytes 40 and 45%, T-lymphocytes 34 and 39, B-lymphocytes 34 and 46%.
    After a course of oxygen therapy, serological reactions are negative. The patient is in the dispensary. The therapy carried out in combination with oxygenbarotherapy led to the normalization of immunological parameters.
    As a result of the application of the method, the terms of treatment of patients with seroresistant forms of syphilis are reduced by 1.5 times. The effectiveness of treatment increases by 15%.
    Claim
    A method for the treatment of patients with seroresistant forms of syphilis, including the introduction of medicinal substances, characterized in that, in order to reduce the duration of treatment, oxygen barotherapy is additionally carried out at an oxygen pressure of 0.25 MPa lasting 60 minutes daily.
    权利要求:
    Claims (1)
    [1]
    The method of treatment of patients with seroresistant forms of syphilis relates to the field of medicine, in particular to dermatology and venereology. The aim of the invention is to reduce the time of treatment, for which, along with drug therapy, oxygen-oxygen therapy is performed at an oxygen pressure of 0.25 MPa and an exposure of 60 minutes. The use of the method in clinical practice will reduce the treatment time by 1.5 times, increase the effectiveness of treatment by 15% due to early negative serological reactions in patients with this pathology.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1496629A3|1989-07-23|Device for controlling speed of a.c. single-phase trolley car
    US4650587A|1987-03-17|Ammonia scavenger
    Peterson et al.1971|Immunological responses to L-asparaginase
    Goldblum et al.1975|Antibody-forming cells in human colostrum after oral immunisation
    Koffler et al.1973|The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases
    Prinz et al.1994|Treatment of severe atopic dermatitis with extracorporeal photopheresis
    Kapp et al.1975|Genetic control of immune responses in vitro. VI. Experimental conditions for the development of helper T-cell activity specific for the terpolymer L-glutamic aicd60-L-alanine30-L-tyrosine10 | in nonresponder mice.
    Weiner et al.1976|Anti-immunoglobulin stimulation of murine lymphocytes: II. Identification of cell surface target molecules and requirements for cross-linkage
    Kagnoff1980|Effects of antigen-feeding on intestinal and systemic immune responses: IV. Similarity between the suppressor factor in mice after erythrocyte-lysate injection and erythrocyte feeding
    Hechemy et al.1983|Absorption of Rickettsia rickettsii antibodies by Rickettsia rickettsii antigens in four diagnostic tests
    Bhatti et al.1990|Encephalitis due to Epstein-Barr virus
    Neta et al.1973|Specific depression of delayed hypersensitivity to purified proteins, with relation to production of circulating antibody
    Dorrington et al.1966|The proteolysis of immunoglobulin G with long-acting thyroid-stimulating activity
    Vestergaard et al.1980|Type-specific herpes-simplex-virus antibodies in patients with recurrent duodenal ulcer
    Beh1979|Antibody-containing cell response in lymph of sheep after intra-intestinal infusion of ovalbumin with and without DEAE-dextran.
    SU1496794A1|1989-07-30|Method of treatment of patients ill with seroresistant forms of syphilis
    RU2112543C1|1998-06-10|Immunomodulating drug
    D'Almeida et al.1981|Studies on human spermatozoa autoantigens. I. Fractionation of sperm membrane antigens: evidence of three antigenic systems.
    WO1986005400A1|1986-09-25|Antigens, antibodies and their uses
    Liedtke et al.1994|Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation
    CN1034986C|1997-05-28|Immunogenic composite pharmaceutics and its preparation method
    SU1169659A1|1985-07-30|Method of preventing complications when treating patients with gonovaccine
    Bruckbauer et al.1997|Sudeck's atrophy in Lyme borreliosis
    Streichhan et al.1995|Bioavailability of therapeutically used hydrolytic enzymes
    Arnon1980|A Synthetic Copolymer of Amino Acids in a Clinical Trial for MS Therapy
    同族专利:
    公开号 | 公开日
    JPS58179803U|1983-12-01|
    JPH0329934Y2|1991-06-25|
    CA1204196A|1986-05-06|
    US4483148A|1984-11-20|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3704760A|1971-06-22|1972-12-05|Oscar Kogyo Kk|Electropneumatic propelling system for vehicles|
    DE2943519A1|1979-10-27|1981-05-07|Volkswagenwerk Ag|DRIVE FOR A VEHICLE WITH AN INTERNAL COMBUSTION ENGINE AND AN ELECTRIC MOTOR|
    JPS6112442B2|1980-11-13|1986-04-08|Toyo Denki Seizo Kk|US5293947A|1991-09-03|1994-03-15|Wagner Mining And Construction Equipment Co.|Variable speed AC electric drive vehicle|
    PE20010833A1|1999-12-20|2001-09-08|Siemens Energy And Automation Inc|SYSTEM, PROCEDURE AND APPARATUS FOR CONNECTING ELECTRICAL SOURCES IN SERIES UNDER FULL LOAD|
    JP4182709B2|2002-08-30|2008-11-19|株式会社ダイフク|Traveling control method of traveling body|
    DE10256705B4|2002-12-04|2007-02-01|Siemens Ag|Non-rail vehicle|
    CN102574524A|2009-10-27|2012-07-11|日立建机株式会社|Electric drive vehicle|
    JP5592832B2|2011-05-17|2014-09-17|日立建機株式会社|Electric drive dump truck|
    JP5710386B2|2011-06-02|2015-04-30|日立建機株式会社|Electric drive dump truck|
    JP5706253B2|2011-07-04|2015-04-22|日立建機株式会社|Electric drive dump truck|
    JP5585790B2|2011-09-27|2014-09-10|日立建機株式会社|Electric drive dump truck|
    JP5585791B2|2011-09-27|2014-09-10|日立建機株式会社|Electric drive dump truck|
    JP6433710B2|2014-07-30|2018-12-05|株式会社東芝|Vehicle system and control method thereof|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    JP1982076952U|JPH0329934Y2|1982-05-27|1982-05-27|
    [返回顶部]